A5005423243- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Biosensors and Analytical Detection
- Advanced biosensing and bioanalysis techniques
Vårdcentralen Teleborg
2021
Using saliva samples would facilitate sample collection, diagnostic feasibility, and mass screening of SARS-CoV-2. We tested two rapid antigen (RAD) immunochromatographic tests designed for detection SARS-CoV-2 in saliva: Rapid Response™ COVID-19 Antigen Test Cassette oral fluids DIAGNOS™ Saliva Test. Evaluation limit was performed with purified nucleocapsid protein live virus. Sensitivity specificity were further evaluated reverse transcription quantitative PCR (RT-qPCR) positive negative...
Abstract Background The COVID-19 pandemic has highlighted the need for rapid, cost effective and easy-to-use diagnostic tools SARS-CoV-2 rapid antigen detection (RAD) use in point of care settings or as self-tests, to limit disease transmission. Using saliva samples would further greatly facilitate sample collection, feasibility, mass screening. Objective We tested two immunochromatographic tests designed saliva: Rapid Response™ Antigen Test Cassette oral fluids (Rapid Response) DIAGNOS™...